{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:48:36Z","timestamp":1761392916961},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":5143,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1046\/j.0022-202x.2001.00032.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T04:37:48Z","timestamp":1047443868000},"page":"153-156","source":"Crossref","is-referenced-by-count":8,"title":["Standard Treatment: The Role of Antihistamines"],"prefix":"10.1016","volume":"6","author":[{"given":"Hans F.","family":"Merk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0010","first-page":"47","article-title":"Histamine release by antihistamines","volume":"119","author":"Arunlakshana","year":"1953","journal-title":"J Physiol"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0015","first-page":"55","article-title":"Histamine modulation of lymphocyte biology: membrane receptors, signal transduction and functions","volume":"7","author":"Beer","year":"1987","journal-title":"Crit Rev Immunol"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0020","series-title":"Histamine and H1-Receptor Antagonists in Allergic Diseases","first-page":"33","article-title":"Molecular identification of the histamine H1-receptor in humans","author":"Chowdhury","year":"1996"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0025","series-title":"Histamine and H1-Receptor Antagonists in Allergic Diseases","first-page":"117","article-title":"H1-receptor antagonists: antiallergic effects in vitro","author":"Church","year":"1996"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0030","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.4049\/jimmunol.161.5.2586","article-title":"Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors","volume":"161","author":"Elenkov","year":"1998","journal-title":"J Immunol"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2222.1999.00004.x-i1","article-title":"Histamine and the antiallergic antihistamines: a history of their discoveries","volume":"29","author":"Emanuel","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0040","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics eighth edition","first-page":"575","article-title":"Histamine, bradykin, 5-hydroxytryptamine, and their antagonists","author":"Garrison","year":"1990"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","article-title":"Randomized double-blind study of cyclosporin in chronic \u201cidiopathic\u201d urticaria","volume":"143","author":"Grattan","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0050","series-title":"Allergic Skin Disease","first-page":"171","article-title":"Urticaria and angioedema","author":"Greaves","year":"2000"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1398-9995.1998.tb03867.x","article-title":"Differential effects of new generation H1-receptor antagonists in pruritic dermatoses","volume":"53","author":"Henz","year":"1998","journal-title":"Allergy"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0060","first-page":"253","article-title":"International Union of Pharmacology. XIII. Classification of histamine receptors","volume":"49","author":"Hill","year":"1997","journal-title":"Pharmcol Rev"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0065","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2249.1997.3791276.x","article-title":"Different modulation by histamine of IL-4 and interferon-gamma (IFN-gamma) release according to the phenotype of human Th0, Th1 and Th2 clones","volume":"108","author":"Lagier","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0070","series-title":"Histamine and H1-Receptor Antagonists in Allergic Diseases","first-page":"1","article-title":"Histamine receptors. Specific ligands, receptor biochemistry, and signal transduction","author":"Leurs","year":"1996"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0075","series-title":"The Urticarias","first-page":"222","article-title":"Histamine release in cold urticaria \u2013 effect of ketotifen and oxatomide","author":"Merk","year":"1985"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0080","series-title":"Dermatopharmakologie und Dermatotherapie","author":"Merk","year":"1992"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0085","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1046\/j.1365-2222.1999.00611.x","article-title":"Specific inhibition of TH2-type cytokine production from human peripheral T cells by terfenadine in vitro","volume":"29","author":"Munakata","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0090","series-title":"Histamine and H1-Receptor Antagonists in Allergic Diseases","first-page":"145","article-title":"H1-receptor antagonists: Antiallergic effects in humans","author":"Nacliero","year":"1996"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00003495-200059020-00003","article-title":"Important drug interactions in dermatology","volume":"59","author":"Roos","year":"2000","journal-title":"Drugs"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000029939","article-title":"Histamine receptors on lymphocytes: Distribution and functional significance","volume":"13","author":"Sachs","year":"2000","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0105","series-title":"Histamine and H1-Receptor Antagonists in Allergic Diseases","first-page":"273","article-title":"H1-receptor antagonists in chronic urticaria","author":"Sim","year":"1996"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0110","series-title":"Allergic Skin Disease","first-page":"477","article-title":"Antihistamines (H1- and H2-receptor antagonists) in skin disease","author":"Simons","year":"2000"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00003495-200059020-00020","article-title":"Fexofenadine. A review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria","volume":"59","author":"Simpson","year":"2000","journal-title":"Drugs"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0120","first-page":"1584","article-title":"Was ist Juckreiz","volume":"34","author":"St\u00fcttgen","year":"1984","journal-title":"Therapiewoche"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1398-9995.2000.00002.x","article-title":"The clinical efficacy of antihistamines in the skin","volume":"55","author":"Tharp","year":"2000","journal-title":"Allergy"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1034\/j.1398-9995.2000.055supp60005.x","article-title":"Factors involved in the absence of sedative effects by the second-generation antihistamines","volume":"55","author":"Timmermann","year":"2000","journal-title":"Allergy"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.pa.36.040196.001313","article-title":"Cardiac actions of antihistamines","volume":"36","author":"Woosley","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1046\/j.0022-202x.2001.00032.x_bb0140","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1476-5381.1995.tb16386.x","article-title":"Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography","volume":"116","author":"Yanai","year":"1995","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15528960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15528960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T02:48:14Z","timestamp":1682131694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15528960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S0022202X15528960"],"URL":"https:\/\/doi.org\/10.1046\/j.0022-202x.2001.00032.x","relation":{},"ISSN":["1087-0024"],"issn-type":[{"value":"1087-0024","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}